Raymond T Keane - Net Worth and Insider Trading
Raymond T Keane Net Worth
The estimated net worth of Raymond T Keane is at least $1 Million dollars as of 2024-11-13. Raymond T Keane is the SVP General Counsel & CCO of ARIAD Pharmaceuticals Inc and owns about 62,096 shares of ARIAD Pharmaceuticals Inc (ARIA) stock worth over $1 Million. Details can be seen in Raymond T Keane's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Raymond T Keane has not made any transactions after 2013-07-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Raymond T Keane
Raymond T Keane Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Raymond T Keane owns 1 companies in total, including Cullinan Therapeutics Inc (CGEM) .
Click here to see the complete history of Raymond T Keane’s form 4 insider trades.
Insider Ownership Summary of Raymond T Keane
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CGEM | Cullinan Therapeutics Inc | 2021-01-07 | Chief Legal Officer |
Raymond T Keane Latest Holdings Summary
Raymond T Keane currently owns a total of 1 stock. Raymond T Keane owns 62,096 shares of ARIAD Pharmaceuticals Inc (ARIA) as of July 18, 2013, with a value of $1 Million.
Latest Holdings of Raymond T Keane
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARIA | ARIAD Pharmaceuticals Inc | 2013-07-18 | 62,096 | 23.99 | 1,489,683 |
Holding Weightings of Raymond T Keane
Raymond T Keane Form 4 Trading Tracker
According to the SEC Form 4 filings, Raymond T Keane has made a total of 0 transactions in ARIAD Pharmaceuticals Inc (ARIA) over the past 5 years. The most-recent trade in ARIAD Pharmaceuticals Inc is the sale of 8,000 shares on July 18, 2013, which brought Raymond T Keane around $158,320.
Insider Trading History of Raymond T Keane
- 1
Raymond T Keane Trading Performance
Raymond T Keane Ownership Network
Ownership Network List of Raymond T Keane
Ownership Network Relation of Raymond T Keane
Raymond T Keane Owned Company Details
What does Cullinan Therapeutics Inc do?
Who are the key executives at Cullinan Therapeutics Inc?
Raymond T Keane is the Chief Legal Officer of Cullinan Therapeutics Inc. Other key executives at Cullinan Therapeutics Inc include See Remarks Jennifer Michaelson , Acting Chief Business Officer Savill Corrine , and director & President and CEO Nadim Ahmed .
Cullinan Therapeutics Inc (CGEM) Insider Trades Summary
Over the past 18 months, Raymond T Keane made no insider transaction in Cullinan Therapeutics Inc (CGEM). Other recent insider transactions involving Cullinan Therapeutics Inc (CGEM) include a net sale of 102,710 shares made by Jennifer Michaelson , a net sale of 5,361 shares made by Jeffrey Trigilio , and a net sale of 3,027 shares made by Jeffrey Alan Jones .
In summary, during the past 3 months, insiders sold 16,000 shares of Cullinan Therapeutics Inc (CGEM) in total and bought 0 shares, with a net sale of 16,000 shares. During the past 18 months, 239,108 shares of Cullinan Therapeutics Inc (CGEM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 239,108 shares.
Cullinan Therapeutics Inc (CGEM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cullinan Therapeutics Inc Insider Transactions
Raymond T Keane Mailing Address
Above is the net worth, insider trading, and ownership report for Raymond T Keane. You might contact Raymond T Keane via mailing address: C/o Ariad Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
